These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7771256)

  • 41. Nitroxides as antioxidants: Tempol protects against EO9 cytotoxicity.
    Samuni AM; DeGraff W; Krishna MC; Mitchell JB
    Mol Cell Biochem; 2002; 234-235(1-2):327-33. PubMed ID: 12162451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Demonstration of secondary free radicals and the role of calpain in functional changes associated with the myocardial ischemia-reperfusion sequence].
    Perrin C; Vergely C; Zeller M; Maupoil V; Rochette L
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):931-6. PubMed ID: 10989732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensive effect of mitochondria-targeted proxyl nitroxides.
    Dikalova AE; Kirilyuk IA; Dikalov SI
    Redox Biol; 2015; 4():355-62. PubMed ID: 25677087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tempol, a stable free radical, is a novel murine radiation protector.
    Hahn SM; Tochner Z; Krishna CM; Glass J; Wilson L; Samuni A; Sprague M; Venzon D; Glatstein E; Mitchell JB
    Cancer Res; 1992 Apr; 52(7):1750-3. PubMed ID: 1551104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effect of nitronyl nitroxide-amino acid conjugates on liver ischemia-reperfusion induced injury in rats.
    Bi W; Cai J; Xue P; Zhang Y; Liu S; Gao X; Li M; Wang Z; Baudy-Floc'h M; Green SA; Bi L
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1788-94. PubMed ID: 18328700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of aromatic nitroxides on hemolysis of human erythrocytes entrapped with isolated hemoglobin chains.
    Gabbianelli R; Falcioni G; Santroni AM; Caulini G; Greci L; Damiani E
    Free Radic Biol Med; 1997; 23(2):278-84. PubMed ID: 9199890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.
    Rak R; Chao DL; Pluta RM; Mitchell JB; Oldfield EH; Watson JC
    J Neurosurg; 2000 Apr; 92(4):646-51. PubMed ID: 10761655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetics and mechanism of the reaction of a nitroxide radical (tempol) with a phenolic antioxidant.
    Aliaga C; Lissi EA; Augusto O; Linares E
    Free Radic Res; 2003 Mar; 37(3):225-30. PubMed ID: 12688417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Catalytic Reaction of Nitroxides with Peroxyl Radicals and Its Relevance to Their Cytoprotective Properties.
    Griesser M; Shah R; Van Kessel AT; Zilka O; Haidasz EA; Pratt DA
    J Am Chem Soc; 2018 Mar; 140(10):3798-3808. PubMed ID: 29451786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitroxides scavenge myeloperoxidase-catalyzed thiyl radicals in model systems and in cells.
    Borisenko GG; Martin I; Zhao Q; Amoscato AA; Kagan VE
    J Am Chem Soc; 2004 Aug; 126(30):9221-32. PubMed ID: 15281811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological Relevance of Free Radicals and Nitroxides.
    Prescott C; Bottle SE
    Cell Biochem Biophys; 2017 Jun; 75(2):227-240. PubMed ID: 27709467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TEMPOL, a membrane-permeable radical scavenger, attenuates gastric mucosal damage induced by ischemia/reperfusion: a key role for superoxide anion.
    Abdallah DM; El-Abhar HS; Abdel-Aziz DH
    Eur J Pharmacol; 2009 Jan; 603(1-3):93-7. PubMed ID: 19087872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The stable nitroxide, tempol, attenuates the effects of peroxynitrite and oxygen-derived free radicals.
    Thiemermann C; McDonald MC; Cuzzocrea S
    Crit Care Med; 2001 Jan; 29(1):223-4. PubMed ID: 11176194
    [No Abstract]   [Full Text] [Related]  

  • 54. Stable nitroxide Tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia.
    Kato N; Yanaka K; Hyodo K; Homma K; Nagase S; Nose T
    Brain Res; 2003 Jul; 979(1-2):188-93. PubMed ID: 12850585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging.
    Cotrim AP; Hyodo F; Matsumoto K; Sowers AL; Cook JA; Baum BJ; Krishna MC; Mitchell JB
    Clin Cancer Res; 2007 Aug; 13(16):4928-33. PubMed ID: 17699873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells.
    Krishna MC; DeGraff W; Tamura S; Gonzalez FJ; Samuni A; Russo A; Mitchell JB
    Cancer Res; 1991 Dec; 51(24):6622-8. PubMed ID: 1660344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic and clinical applications of nitroxide compounds.
    Soule BP; Hyodo F; Matsumoto K; Simone NL; Cook JA; Krishna MC; Mitchell JB
    Antioxid Redox Signal; 2007 Oct; 9(10):1731-43. PubMed ID: 17665971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurophysiological consequences of nitroxide antioxidants.
    Hahn SM; Lepinski DL; DeLuca AM; Mitchell JB; Pellmar TC
    Can J Physiol Pharmacol; 1995 Mar; 73(3):399-403. PubMed ID: 7648519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel antioxidants in anthracycline cardiotoxicity.
    Hideg K; Kálai T
    Cardiovasc Toxicol; 2007; 7(2):160-4. PubMed ID: 17652823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PBN spin trapping of free radicals in the reperfusion-injured heart. Limitations for pharmacological investigations.
    Vrbjar N; Zöllner S; Haseloff RF; Pissarek M; Blasig IE
    Mol Cell Biochem; 1998 Sep; 186(1-2):107-15. PubMed ID: 9774191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.